About Bioline
Founded in 1992, Bioline develops molecular biology reagents and workflow solutions for nucleic acid research, molecular diagnostics and applied genomics. The company specialises in products for PCR, qPCR, reverse transcription, nucleic acid extraction and next-generation sequencing, providing researchers with tools to analyse DNA and RNA with high sensitivity and reproducibility. Bioline’s expertise supports applications across gene expression analysis, pathogen detection, genetic testing, synthetic biology, agricultural biotechnology and translational research. Its technologies are designed to streamline molecular workflows from sample preparation through amplification and downstream analysis.
The company’s portfolio includes PCR and qPCR master mixes, reverse transcriptases, DNA polymerases, extraction kits, cDNA synthesis reagents and products for NGS library preparation. Notable product families include MyTaq™, SensiFAST™, Meridian Bioscience® molecular reagents and a range of enzymes and kits developed for research and diagnostic workflows. Bioline products are widely used in academic, clinical, industrial and public health laboratories for molecular assay development, gene expression studies, infectious disease research and genomic analysis.
Europa Biosite’s subsidiaries distribute for Bioline Reagents in Denmark, Estonia, Iceland, Latvia, Lithuania, Norway and Sweden.